Catalyst Wire Dossier Catalyst Wire Dossier

V502-003 Broad Spectrum HPV Vaccine

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V502-003 Broad Spectrum HPV Vaccine, covering 2015-06-19 to 2015-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) [Phase 2]

See pricing